Germany Hospital Hematology and Flow Cytometry Analyzers and Reagents, 2019-2023: Market Shares and Strategies, Segmentation Forecasts, Innovative Technologies, Latest Instrumentation

Germany Hospital Hematology and Flow Cytometry Analyzers and Reagents, 2019-2023: Market Shares and Strategies, Segmentation Forecasts, Innovative Technologies, Latest Instrumentation

  • July 2019 •
  • 233 pages •
  • Report ID: 5794788 •
  • Format: PDF
Germany Hospital Hematology and Flow Cytometry Analyzers and Reagents, 2019-2023: Market Shares and Strategies, Segmentation Forecasts, Innovative Technologies, Latest Instrumentation

This new report contains 233 pages, 15 tables, and presents a comprehensive analysis of the German hospital hematology and flow cytometry markets, including: 

  • Major issues pertaining to the German hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.  
  • Five-year volume and sales forecasts for major hematology and flow cytometry tests performed in German hospitals. 
  • Annual placements and installed base estimates for major automated and semiautomated hematology analyzers and flow cytometers.  
  • Review of current instrumentation technologies, and a feature comparison
    of high-, medium-, and low-volume/POC analyzers. 
  • Five-year reagent and instrument sales forecasts. 
  • Sales and market shares of leading reagent and instrument suppliers. 
  • Review of current and emerging technologies, and their potential market applications. 
  • Product development opportunities for instruments, consumables, and auxiliary products. 
  • Profiles of major current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in RandD, collaborative arrangements, and business strategies. 
  • Business opportunities and strategic recommendations for suppliers.

    Contains 233 pages and 15 tables


    Companies Profiled
    Competitive Assessments

    - Abbott
    - Agilent Technologies
    - Beckman Coulter/Danaher
    - Becton Dickinson
    - Bio-Rad
    - CellaVision
    - Horiba
    - Nihon Kohden
    - Ortho-Clinical Diagnostics
    - Roche
    - Siemens Healthineers
    - Sysmex